Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
First Spark Ventures does not develop drugs or therapies directly but invests in early-stage deep tech and biotech startups. Its healthcare/life sciences investments include companies developing therapeutic platforms for premature infants' lung development (Vitara), multi-valent biopolymer drug technologies (Valitor), musculoskeletal health measurement devices (Figur8), outpatient surgical care solutions (Oath Surgical), precision medicine for chronic disease care (Curve Biosciences), and more. The clinical results are specific to each portfolio company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on First Spark Ventures.